Xrf Scientific Limited · ASX:XRF

Xrf Scientific — Investor Presentation (March 2014)

15 slides from Xrf Scientific's investor presentation, Mar 18, 2014

  1. Slide 1: Investor Presentation March 2014

    For personal use only Investor Presentation March 2014

  2. Slide 2: Corporate Snapshot

    Corporate Snapshot For personal use only Capital Structure Share Price Performance – 1 Year Shares on issue 132,157,097 $0.40 Options on issue Nil Share price 24c $0.35 Market cap $31.7m $0.30 Cash (28/02/2014) $5.3m (4 cents per share) $0.25 Debt (28/02/2014) $0.0m $0.20 Enterprise Value $26.4m (20

  3. Slide 3: Company Overview

    Company Overview For personal use only  Manufacturer of consumables and equipment for mining and industry, for X‐Ray Fluorescence (XRF) analysis – a powerful long‐established analytical technique, vital to the discovery, evaluation, qualification and production of most metals (except gold)  Office

  4. Slide 4: Our Products

    Our Products X‐Ray Flux Platinum Labware Fusion Machines For personal use only Products Industry Samples Shipping Laboratory Samples Exploration Stock & Blend Mining Rail 4

  5. Slide 5: The XRF Analysis Process

    The XRF Analysis Process For personal use only Drill core is sent from the field to the laboratory The drill core is then processed into a fine dust The glass disk is presented into an x‐ray spectrometer for analysis The mineral dust is then fused into a glass bead using XRF Scientific’s products 5

  6. Slide 6: Results Snapshot

    Results Snapshot For personal use only Revenue up 16% on 2H13 EBITDA down 10% on 2H13 NPAT down 12% on 2H13 2.3 3.5 13.2 13.4 2.0 12.2 11.5 2.9 10.5 2.7 2.6 1.6 1.6 2.3 1.5 9.1 1.4 8.6 2.1 1.7 1.0 1H11 2H11 1H12 2H12 1H13 2H13 1H14 1H11 2H11 1H12 2H12 1H13 2H13 1H14 1H11 2H11 1H12 2H12 1H13 2H13 1H1

  7. Slide 7: Full Year Results – Overview

    Full Year Results – Overview For personal use only ($m) 1H14 2H13 1H13 Change on 2H13 Sales revenue 10.5 9.1 13.4 16% EBITDA 2.1 2.3 3.5 (10%) Profit before tax 1.9 2.1 3.3 11% Net profit after tax 1.4 1.5 2.3 (12%) Earnings per share (cents) 1.0 1.2 1.7 (12%) Weighted average no. of shares 132,157,

  8. Slide 8: Cash Flow Statements

    Cash Flow Statements For personal use only ($m) 1H14 2H13 1H13 Change on 2H13 Net cash inflow from operating activities 1.0 2.3 1.8 (57%) Net cash (outflow) from investing activities (2.4) (0.3) (0.5) 633% Net cash inflow/(outflow) from financing activities (2.2) 0 (1.4) 100% Cash at start of period

  9. Slide 9: Robust Balance Sheet

    Robust Balance Sheet For personal use only ($m) 1H14 2H13 Change % Cash and cash equivalents 5.0 8.6 (43%) Highlights: Trade and other receivables 3.5 3.5 (2%)  Strong cash balance of $5.0m Inventories 2.9 2.7 7%  Zero debt Other assets 0.4 0.3 12%  Kitco Labware acquisition for Investment in con

  10. Slide 10: Consumables

    Consumables For personal use only  Overview for 1H14: ($m) 1H14 2H13 1H13 Sales revenue 3.4 3.4 3.9  Revenue flat on 2H13 Change in % 0% (13%) 0%  NPBT down 8% on 2H13  Minor impact on NPBT from forex and one‐off NPBT 1.3 1.4 1.4 costs Change in % (8%) (4%) (5%)  Low levels of exploration relat

  11. Slide 11: Precious Metals

    Precious Metals For personal use only  Overview for 1H14: ($m) 1H14 2H13 1H13 Sales revenue 4.8 3.2 5.3  Revenue up 53% on 2H13 Change in % 53% (41%) (4%)  NPBT down 1% on 2H13  Completion and integration of Kitco Labware NPBT 0.5 0.5 0.9 acquisition in Montreal, Quebec Change in % (1%) (44%) 1%

  12. Slide 12: Capital Equipment

    Capital Equipment For personal use only  Overview for 1H14: ($m) 1H14 2H13 1H13 Sales revenue 2.9 3.2 5.2  Revenue down 9% on 2H13 Change in % (9%) (40%) 32%  NPBT down 32% on 2H13  Weak capital equipment conditions NPBT 0.2 0.3 0.9  Launch of flagship xrFuse 6 electric fusion Change in % (32%)

  13. Slide 13: Growth Strategy

    Growth Strategy For personal use only Acquisitions • Consumables or services, CAPEX products with repeat revenue • Exposure to additional commodities • Expansion of sales in existing product lines Organic Growth • Geographical expansion • New product releases • Adoption of XRF and fusion as an analy

  14. Slide 14: Contact Information

    Contact Information For personal use only Tel: (08) 9244 0600 98 Guthrie St. Osborne Park WA Vance Stazzonelli – CEO vance@xrfscientific.com 14

  15. Slide 15: Disclaimer

    Disclaimer For personal use only No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make no representation, warranty or undertaking, express or implied, as to the adequacy, accuracy, completeness or reasonable

XRF Scientific — Investor Presentation (March 2014) on 6ix